Search research articles
Contact Us
Filters
Showing results (1401-1410 of 1,441) with videos related to
Page
of 145
Sort By:
Nature
|
August 23, 2002
Chemical investigation of hassium (element 108)
Ch E Düllmann, W Brüchle, R Dressler, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
DREDge: robust motion correction for high-density extracellular recordings across species
Charlie Windolf, Han Yu, Angelique C Paulk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial
Elias K Mai, Uta Bertsch, Ema Pozek, et al.
Forensic Science International. Genetics
|
February 18, 2018
Body fluid identification using a targeted mRNA massively parallel sequencing approach - results of a EUROFORGEN/EDNAP collaborative exercise
S Ingold, G Dørum, E Hanson, et al.
The Lancet. HIV
|
February 26, 2026
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials
Thumbi Ndung'u, Krista L Dong, Donn J Colby, et al.
Journal of Investigational Allergology & Clinical Immunology
|
November 8, 2023
Factors Affecting the Safety and Effectiveness of Venom Immunotherapy
L Arzt-Gradwohl, S A Herzog, W Aberer, et al.
Journal of the American Society of Nephrology : JASN
|
June 2, 2017
Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children
Agnes Trautmann, Sven Schnaidt, Beata S Lipska-Ziętkiewicz, et al.
American Journal of Hematology
|
October 2, 2025
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial
Katja Sockel, Christoph Röllig, Anke Mütherig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial
Jia Xiang Jin, Varun R Ginde, Stefanie Huhn, et al.
Allergy
|
February 19, 2021
β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy
Gunter Johannes Sturm, Sereina Annik Herzog, Werner Aberer, et al.
Page
of 145
Search research articles
Search
Showing results (1401-1410 of 1,441) with videos related to
Sort By:
Page
of 145
Nature
|
August 23, 2002
Chemical investigation of hassium (element 108)
Ch E Düllmann, W Brüchle, R Dressler, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
DREDge: robust motion correction for high-density extracellular recordings across species
Charlie Windolf, Han Yu, Angelique C Paulk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial
Elias K Mai, Uta Bertsch, Ema Pozek, et al.
Forensic Science International. Genetics
|
February 18, 2018
Body fluid identification using a targeted mRNA massively parallel sequencing approach - results of a EUROFORGEN/EDNAP collaborative exercise
S Ingold, G Dørum, E Hanson, et al.
The Lancet. HIV
|
February 26, 2026
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials
Thumbi Ndung'u, Krista L Dong, Donn J Colby, et al.
Journal of Investigational Allergology & Clinical Immunology
|
November 8, 2023
Factors Affecting the Safety and Effectiveness of Venom Immunotherapy
L Arzt-Gradwohl, S A Herzog, W Aberer, et al.
Journal of the American Society of Nephrology : JASN
|
June 2, 2017
Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children
Agnes Trautmann, Sven Schnaidt, Beata S Lipska-Ziętkiewicz, et al.
American Journal of Hematology
|
October 2, 2025
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial
Katja Sockel, Christoph Röllig, Anke Mütherig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial
Jia Xiang Jin, Varun R Ginde, Stefanie Huhn, et al.
Allergy
|
February 19, 2021
β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy
Gunter Johannes Sturm, Sereina Annik Herzog, Werner Aberer, et al.
Page
of 145